ELOXATIN Βραζιλία - Πορτογαλικά - ANVISA (Agência Nacional de Vigilância Sanitária)

eloxatin

sanofi medley farmacÊutica ltda. - oxaliplatina - citostaticos alquilantes

EVOXALI Βραζιλία - Πορτογαλικά - ANVISA (Agência Nacional de Vigilância Sanitária)

evoxali

farmarin industria e comercio ltda - oxaliplatina - citostaticos alquilantes

LIBOXAL Βραζιλία - Πορτογαλικά - ANVISA (Agência Nacional de Vigilância Sanitária)

liboxal

laboratÓrios libra do brasil ltda - oxaliplatina - citostaticos alquilantes

BIOEZULEN Βραζιλία - Πορτογαλικά - ANVISA (Agência Nacional de Vigilância Sanitária)

bioezulen

achÉ laboratÓrios farmacÊuticos s.a - oxaliplatina - citostaticos alquilantes

Teysuno Ευρωπαϊκή Ένωση - Πορτογαλικά - EMA (European Medicines Agency)

teysuno

nordic group b.v. - tegafur, gimeracil, oteracil - neoplasias de estômago - agentes antineoplásicos - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.